Target type: molecularfunction
Combining with adrenomedullin to initiate a change in cell activity. [GOC:ai]
Adrenomedullin receptor activity is a molecular function associated with the transmembrane receptor that binds adrenomedullin, a potent vasodilator and hypotensive peptide. This receptor, also known as the calcitonin receptor-like receptor (CLR), belongs to the class B G protein-coupled receptors (GPCRs). Upon binding of adrenomedullin, the receptor activates downstream signaling pathways, primarily involving the G protein Gs, leading to the production of cAMP and the activation of protein kinase A (PKA). This signaling cascade results in a multitude of physiological effects, including:
* **Vasodilation:** Adrenomedullin receptor activation leads to relaxation of vascular smooth muscle, causing vasodilation and lowering blood pressure.
* **Cardioprotection:** Adrenomedullin plays a protective role in the heart, reducing myocardial damage and inflammation.
* **Anti-inflammatory effects:** Adrenomedullin receptor activation inhibits the production of pro-inflammatory cytokines, contributing to its overall anti-inflammatory properties.
* **Regulation of fluid balance:** Adrenomedullin receptor signaling affects renal function, influencing sodium and water excretion.
* **Regulation of cell growth and differentiation:** Adrenomedullin receptor activation influences cell proliferation and differentiation in various tissues.
The adrenomedullin receptor is expressed in a wide range of tissues and organs, including the cardiovascular system, kidneys, lungs, brain, and gastrointestinal tract. Its diverse functions highlight its significant role in maintaining physiological homeostasis and regulating various physiological processes.'
"
Protein | Definition | Taxonomy |
---|---|---|
Calcitonin gene-related peptide type 1 receptor | A calcitonin gene-related peptide type 1 receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q16602] | Homo sapiens (human) |
Receptor activity-modifying protein 3 | A receptor activity-modifying protein 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60896] | Homo sapiens (human) |
Receptor activity-modifying protein 2 | A receptor activity-modifying protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60895] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
haloperidol | haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety. Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
azaperone | azaperone : An N-arylpiperazine that is 2-(piperazin-1-yl)pyridine in which the amino hydrogen is replaced by a 3-(4-fluobenzoyl)propyl group. Used mainly as a tranquiliser for pigs and elephants. Azaperone: A butyrophenone used in the treatment of PSYCHOSES. | aminopyridine; aromatic ketone; monofluorobenzenes; N-alkylpiperazine; N-arylpiperazine; tertiary amino compound | antipsychotic agent; dopaminergic antagonist |
telcagepant | telcagepant: structure in first source | ||
mk 3207 | |||
bms 694153 | |||
(5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1h-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate | |||
mk-8825 | |||
atogepant | atogepant : A secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine. | azaspiro compound; organic heterotetracyclic compound; piperidones; secondary carboxamide; trifluorobenzene | calcitonin gene-related peptide receptor antagonist |